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Abstract
Purpose of review This review examines the delivery of reha-
bilitation care to cancer patients with relation to disease prog-
nosis. This includes the evaluation when patients are referred
for rehabilitation services and the effectiveness of rehabilita-
tion interventions across the cancer continuum.
Recent findings Although prognosticating life expectancy is
difficult, referrals for rehabilitation interventions appear to be
affected by physician attitudes towards patients with advanced
disease, in part because of misconceptions about the nature of
rehabilitation for oncology patients. Rehabilitation may also
be underutilized in long-term survivors with no evidence of
disease. Despite this, our review found that rehabilitation in
advanced disease, end-of-life, geriatric cancer patients, and in
long-term survivors can be beneficial. There is a relative
dearth in studies on rehabilitation interventions specifically
at the end-of-life.
Summary Cancer rehabilitation can be helpful to patients
along the spectrum of cancer prognoses. Examining more ac-
curate ways to prognosticate life expectancy, improving com-
munication and education between oncologists and rehabilita-
tion team members, and modifying survivorship plans to in-
clude patient education on functional changes over time may
improve the delivery of rehabilitation care.
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Introduction
The dynamic and complex nature of oncology patients creates
challenges in providing rehabilitation care. As patients prog-
ress through treatments and/or their disease advances, the re-
habilitation target may move—a goal of independent func-
tioning and returning to work may abruptly change to requir-
ing assistance with activities of daily living and moving to an
accessible home. These changes are even more pronounced
when a patient’s prognosis changes, as someone who is ex-
pected to be a long-term survivor of cancer will undoubtedly
have different rehabilitation goals and expectations than
someone with a life expectancy fewer than 6 months.
The evolution of symptom burden and impaired function as
the disease trajectory advances is an ongoing area of study, but
it is clear that the rehabilitation needs of patients change as
their prognosis does and that all patients across the cancer
continuum potentially have rehabilitation needs. For example,
Beernaert et al. found that patients with advanced cancer re-
port poorer function and increased fatigue and pain compared
to other cancer patients after controlling for age, gender, and
type of cancer [1]. Additionally, patients undergoing initial
cancer treatment with curative intent also had more severe
pain and worse physical function than healthy controls.
We sought to evaluate prognosis as it intersects with deliv-
ering rehabilitation and supportive care services. Using the
search terms listed in Table 1, we found a variety of studies
evaluating the effectiveness of rehabilitation across the spec-
trum of prognosis associated with cancer, though interven-
tions were often not compared between cohorts with different
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prognoses. Many variables confound the evaluation and de-
livery of rehabilitation services across the cancer continuum,
including clinician bias with respect to prognosis, supportive
care needs, difficulty predicting prognosis, and inadequate
care delivery models. In this review, we will discuss these
components vis-à-vis the relationship between prognosis and
cancer rehabilitation, as well as current relevant studies eval-
uating rehabilitation across the cancer continuum.
Physician Attitudes About Rehabilitation in Different
Stages of Disease
Despite efforts to improve patient access to rehabilitation and
supportive services, physician bias regarding rehabilitation
across the spectrum of disease may lead to unmet patient
needs. Spill et al. found that only 8% of the medical oncolo-
gists—compared to 35% of physiatrists—would recommend
a patient with functional goals and advanced cancer (6–
12 months of estimated survival) be admitted to an inpatient
rehabilitation unit, but 70% of the combined cohorts believed
that a patient must fully understand their prognosis before
entering into a comprehensive rehabilitation program [2]. It
is worth pointing out that while physiatrists in general were
more willing to accept a patient with advanced cancer to in-
patient rehabilitation, nearly two-thirds of those surveyed did
not think that a patient with 12 months or less estimated sur-
vival should undergo comprehensive rehabilitation. Another
study found that palliative care physicians would like to better
incorporate rehabilitation in end-of-life care, but when sur-
veyed, they reported concerns that rehabilitation would pro-
vide false hope to patients and that a palliative care service
lacks the knowledge and resources to adequately carry out
high-quality rehabilitation measures [3••]. This disconnect
may be due to perceptions that rehabilitation need be a lengthy
process that will take up a significant proportion of the pa-
tient’s remaining life expectancy. Table 2 outlines physician
attitudes that may be barriers to referral to rehabilitation ser-
vices in cancer patients.
In fact, cancer rehabilitation, when focusing on addressing
specific impairments, may be quite efficient and is effective in
reducing symptom burden [4]. This bias against rehabilitation
in end-of-life scenarios, however, may create imbalanced care
models and lead to patients being undertreated. For physiat-
rists, those who specialize in cancer rehabilitation and there-
fore are more comfortable managing patients with advanced
cancer may be more aggressive in developing rehabilitation
plans. Furthermore, it has been shown that medical oncolo-
gists who are comfortable with end-of-life care are far more
likely to refer for palliative—but not necessarily end-of-life—
services [5].
Physician attitudes about prognosis also appear to be the
most important consideration in initiating palliative systemic
treatment in advanced cancer, as Buiting et al. found that near-
ly half of medical oncologists documented it as part of their
decision making [6]. Performance status, on the other hand,
was only considered in 16% of decisions to provide systemic
treatment, underscoring that life expectancy is often consid-
ered to be more important than physical function when eval-
uating whether or not to aggressively treat patients.
In an attempt to standardize when patients are referred for
rehabilitation based on prognosis, Jarlbaek et al. suggest that
patients who live longer than 2 years post-cancer diagnosis
may be better candidates for rehabilitation programs than hos-
pice and end-of-life care programs. In their study of over
24,000 patients, 78% who died did so within 2 years of cancer
diagnosis, and many of those that lived longer than 2 years
often lived for several more years [7]. This study does not
control for many factors, including cancer diagnosis, and does
not look at the specific rehabilitation needs of patients before
determining whether or not rehabilitation would have been
warranted. For example, a patient who lives 18 months after
cancer diagnosis may derive benefit from a short inpatient
rehabilitation stay if functional impairment is present early
on, or a patient with 3 months to live may have less pain
secondary to rehabilitation interventions.
Challenges in Prognosticating Life Expectancy
It is not clear that providers can accurately predict prognosis.
This is particularly worrisome if physician bias about per-
ceived prognosis is a major factor in determining who receives
rehabilitation care. A recent study found that using an assess-
ment tool—the palliative prognostic score (PaP)—was signif-
icantly more accurate in determining both 30- and 100-day
survival when compared to using the tool combined with cli-
nician prediction, and to clinician assessment alone [8]. Other
studies have also shown objective assessment to be more ac-
curate than clinician gestalt regarding prognosis, particularly
when prognosticating 3 months or less into the future [9].
Rehabilitation may be time consuming, and oncologists
may be biased against referring patients with limited life ex-
pectancies to these services. Because of this, it is important to
factor in patients’ goals of care; for example, some patients
Table 1 Search terms used for data collection for this article
“Cancer prognosis and rehabilitation”a
“Cancer survivorship and rehabilitation”
“Long-term survivors and cancer and rehabilitation”
“Cancer rehabilitation and falls”
“Geriatric and cancer rehabilitation”
“Prognosis and symptom management or rehabilitation or palliative
care”
“Cancer and function and rehabilitation”
“Palliative care and rehabilitation and prognosis”
aMost helpful search term
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with less than 3 months to live may desire to undergo 2 weeks
of inpatient rehabilitation if it reduces caregiver burden.
Unfortunately, patients are generally unsure of their prognosis
and tend to be more optimistic than oncologists, as demon-
strated in a recent study that found 68% of the patients to be
discordant with their oncologists when estimating life expec-
tancy [10]. Another study showed that discordance also exists
between physicians and surrogate decision makers of patients
in 53% of the patients and that factors contributing to this
difference included the need to be feel optimistic to benefit
the patient, religious beliefs, and lack of physician understand-
ing about a patients’ ability to recover from physical and cog-
nitive impairments [11].
Unrealistic expectations about prognosis have the potential
to create unrealistic goals of care. This underscores the need
for effective communication between patients and their oncol-
ogy teams about long-term planning, including rehabilitation
care. Conversely, patients often experience hope and opti-
mism despite understanding their life expectancy. Reasons
for this are multifactorial and not always well-understood by
health professionals but may explain why patients seek restor-
ative interventions such as cancer rehabilitation despite a poor
prognosis [12].
Delivering Rehabilitation and Supportive Care
Across the Continuum
Understanding when to refer patients for rehabilitation ser-
vices presents an ongoing challenge. Numerous organizations
have advocated and developed criteria for evaluation of pa-
tients for rehabilitation needs and other supportive care ser-
vices without a qualifier of patient prognosis [13–15]. The
message is clear: all patients should be evaluated for and pro-
vided access to rehabilitation treatment regardless of when
their cancer treatment began or their estimated life expectancy.
For patients in whom the disease is presumably cured, the
Commission onCancer (COC) has attempted to improve eval-
uation and referrals for long-term care by mandating survivor-
ship care plans (SCP). These serve as a way to inform patients
about potential short- and long-term complications from can-
cer or its treatment, and explain how to obtain supportive care
services [16]. Unfortunately, while SCPs increase the likeli-
hood of patients attending follow-up visits, they do not appear
to increase awareness about the late or long-term effects of
cancer [17], and there is a lack of consensus on format and
delivery of the plans [18].
Furthermore, SCPs provide an early opportunity to inform
patients about potential rehabilitation needs, but they are not
designed for patients with advanced cancer or to inform pa-
tients about functional decline as disease advances and prog-
nosis changes. Although plans of care in advanced cancer
have been proposed, there exists no standard in providing
patients information about symptom management and reha-
bilitation need [19].
For patients with advanced cancer or higher symptom bur-
den, the National Comprehensive Cancer Network (NCCN)
has proposed criteria to determine if patients should be re-
ferred for palliative care services in order to provide symptom
management. Specifically, the NCCN recommends that if pa-
tients display any one of the following six attributes, palliative
care referral should be initiated: (1) uncontrolled symptoms;
(2) moderate-to-severe distress; (3) serious comorbid physical
or psychosocial condition; (4) advanced or progressive dis-
ease without available curative therapy; (5) patient/family
concerns about decision making; (6) or patient/family request
for palliative care [20]. Levy et al. found that referring to
palliative care based on these criteria led to reduced symptom
burden andmore patient referrals [21]. Numerous studies have
shown that early palliative care reduces symptom burden [22,
23], but care delivery is inadequate for reasons that include a
lack of personnel and inefficient and inconsistent referral
mechanisms [24]. For example, one retrospective review of
100 patients at the MD Anderson Cancer Center found that
patients referred early for supportive care may be those who
are younger and have obvious treatment-related side effects
and that radiation oncologists were more likely to refer than
medical oncologists [25]. It is important to note that these
studies show that early intervention reduces symptom burden,
which has not been specifically studied in the context of can-
cer rehabilitation.
A recent meta-analysis of outpatient palliative care referrals
found inconsistent evaluation and referral mechanisms for pa-
tients across the cancer continuum. The most important
criteria for referring a patient were physical symptoms (62%
of the studies in the analysis) and cancer trajectory (62%),
followed by prognosis (33%) and performance status (33%)
Table 2 Physician barriers to
rehabilitation referrals Study Barrier to rehabilitation referral
Spill [2] Poor use of patient time and medical resources at end-of-life, sometimes unnecessary
Runacres [3••] Inadequate training to provide rehabilitation, do not want to give the patient false hope
at end-of-life
Virgo [74] Inadequate awareness and training to evaluate for rehabilitation needs, defensive medicine
Libert [75] Inadequate training to screen for symptoms, insufficient clinic time
Cheville [76] Lack of recognition and documentation of functional deficits
48 Curr Phys Med Rehabil Rep (2017) 5:46–54
[26••]. The analysis concluded that there was inconsistency in
cutoffs of symptom assessment tools and timing for referrals
and that better standardization of the process would improve
identification of supportive care needs of patients.
Rehabilitation in Advanced Cancer and End of Life
As outlined above, uncertainty about the benefits and neces-
sity of rehabilitation in cancer care largely center on patients
with a poor prognosis. This may be due to multiple factors,
including considerations surrounding the appropriateness of
time- and resource-intensive services for patients with limited
life expectancy. While palliative care and hospice at the end-
of-life is generally felt to be important and effective [27, 28],
cancer rehabilitation is not as widely adopted nor understood
in this patient population and may be underutilized [29].
Rehabilitation at the end of life may cover many facets,
including outpatient, inpatient, and hospice-based interven-
tions. Outpatient intervention has the potential to provide rap-
id assessment and relief of symptoms. Referral to a physiatrist
to diagnose and treat neuromusculoskeletal, pain, functional,
and other symptoms should be considered as a part of
impairment-driven rehabilitation [4]. Many patients with ad-
vanced disease seen in a cancer rehabilitation clinic will have
metastases to the bone and/or brain, and physiatrists are well-
equipped to intervene in both scenarios.
Patients with bony metastases may need expert assessment
of lesions to determine stability and proper management. For
example, vertebral metastases often do not require surgical or
radiation-based intervention, though this must be first evalu-
ated systematically based on the location, size, and nature of
each lesion [30]. Physiatrists are often key members of the
multidisciplinary spine oncology team, both in providing this
assessment and the subsequent treatment, including bracing,
exercise, medications, and interventional pain procedures
[31]. Furthermore, rehabilitation and resistance training con-
current with radiation in the presence of axial and peripheral
bone metastases has been shown to improve bone density and
strength without contributing to fractures [32].
Central nervous system lesions also often require physiatric
evaluation and management, as primary and metastatic brain
tumors can create numerous cognitive and neurologic deficits.
Despite the ultimately poor prognosis of these cancers, reha-
bilitation intervention can improve function and quality of life,
safety and independence, and reduce resource utilization by
improving care coordination and preventing injury.
Difficulties in accurately prognosticating survival in the pres-
ence of brain metastases has the potential to reduced appro-
priate rehabilitation utilization. One study of 2700 cases found
that 45% of the estimations were off by 6 or more months, and
18% were off by 12 months. Performance status—which re-
habilitation may improve—and age may be the biggest factors
in determining prognosis in this patient population [33••].
Rehabilitation in the setting of brain metastases involves
managing the effects of both the tumor(s) and the surgery and/
or radiation. Whole brain radiation, for multiple or large le-
sions, can cause significant long-term cognitive impairment
but is becoming less common with the advent of more precise
radiation-based interventions [34]. Risk factors for radiation-
induced cognitive impairment include higher total and frac-
tionated dosing, increased brain volume radiated, combined
chemotherapy, age over 60 years or less than 7 years old, and
premorbid vascular disease [35]. Cognitive rehabilitation may
take many forms and has been shown to improve executive
functioning, working memory, and other areas of cognition to
varying degrees [36] despite a Cochrane review of cognitive
rehabilitation in brain metastases demonstrating no strong ev-
idence to support any one specific non-pharmacologic inter-
vention [37]. Therefore, treatment should be supportive and
multidisciplinary, tailoring to each patient’s needs based on
their symptoms. In addition to cognitive rehabilitation, this
may include pharmacologic management by a physiatrist
and interventions to boost physical activity.
Regardless of the presence of metastases, inpatient rehabil-
itation improves function and is safe in patients with advanced
cancer. Although patients with advanced cancer may utilize
inpatient rehabilitation more than those with controlled dis-
ease [38], Sliwa et al. found that patients with metastases
benefitted from inpatient rehabilitation similarly to patients
without metastatic or advanced disease, regardless of the pres-
ence of common inpatient rehabilitation diagnoses such as
spinal cord injury (SCI), stroke, or neuromuscular disease
[39••]. Furthermore, patients with impairments such as SCI
due to tumor compression have been shown to benefit from
inpatient rehabilitation [40]. One study comparing 143 pa-
tients with malignant spinal cord compression found that pa-
tients with cancer-related SCI had similar length of stay, func-
tional scores, and discharge location compared to non-
traumatic SCI patients without cancer [41]. Inpatient rehabil-
itation has been consistently shown to improve function and
help ensure a safe discharge home in many other advanced
and complex cancer patient populations [42], including brain
tumor [43], hematologic malignancy [44], paraneoplastic dis-
ease [45, 46], and stage II–III tumors [47]. The benefits of
inpatient rehabilitation in cancer patients also appear to be
independent of age [48].
In the end-of-life and hospice setting, rehabilitation inter-
ventions have been shown to improve independence, reduce
anxiety and depression, and improve fatigue, among other
benefits [49–52]. One randomized control trial compared hos-
pice patients who received daily rehabilitation compared to
usual care, and found that the rehabilitation group resulted in
less unmet needs at the end of life in psychological, physical,
activities of daily living, care and support, and pain domains.
The rehabilitation intervention group also utilized fewer re-
sources [53••]. Furthermore, studies have shown that
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musculoskeletal pain is prevalent at the end of life [54], and
the rise of ultrasound-guided procedures is allowing more
rapid intervention for acute pain during hospice, opening av-
enues for physiatric management of end-of-life pain [55].
Finally, it is important to discuss the rehabilitation of geri-
atric patients with cancer. Even when the cancer is early stage,
older patients are at a greater risk for morbidity and mortality,
in part due to cancer treatment accelerating the aging process,
and goal setting must be done in the setting of both the disease
and the patient’s age [56]. Nevertheless, older adults with
cancer have rehabilitation and supportive care needs across
the continuum and should not be overlooked despite what
may seem like a poorer prognosis than younger disease-
matched patients [57]. In fact, Pergolotti et al. found that there
are numerous potentially modifiable functional deficits in
older adults with cancer, but that even when impairments are
identified, rehabilitation services are under-utilized [58]. This
is a larger problem when one considers that over 60% of pain
in geriatric patients at the end of life is musculoskeletal and
that rehabilitation interventions are uniquely suited to address
these symptoms [59].
Another important area of rehabilitation concern is fall risk
in the geriatric cancer patient. Spoelstra et al. found that older
cancer survivors are 16% more likely to experience a fall than
their cancer-free peers [60••], which may be due to multiple
factors, including chemotherapy-induced peripheral neuropa-
thy, deconditioning, and cognitive impairment [61].
Rehabilitation interventions to improve balance, endurance,
strength, and to provide adaptive equipment and pain relief
all can decrease the risk of falls in this population. Studies
have shown that geriatric patient independence with ADLs
is essential to quality of life and survival [62] and that reha-
bilitation interventions are crucial to preventing functional
decline [63]. Despite this, rehabilitation needs in geriatric can-
cer patients may be overlooked despite their requiring and
benefitting from rehabilitation servicesmore than other patient
cohorts.
Rehabilitation in Long-Term Survivors and Those
with a Favorable Prognosis
Although much of the controversy about the efficacy and ap-
propriateness of rehabilitation understandably centers on the
end of life, it is important to note that patients with the oppo-
site prognosis—those whose cancers have been cured and/or
who are expected to have a normal lifespan—may have reha-
bilitation needs overlooked, because lifesaving treatment has
completed, and it is presumed that patients will recover from
deficits over time. This is not always the case, as one study
found that 38.2% of the unmet needs in cancer survivors 2-,
5-, and 10-year post-treatment were physical needs [64]. The
long-term negative effects of cancer and its treatment have
been well documented in the literature and are at the core of
the cancer rehabilitation specialty [65]. Cancer care guidelines
consistently recommend long-term, longitudinal assessment
of supportive care needs, including rehabilitation [13–15].
The decline in function related to cancer treatment occurs
early. For example, breast cancer patients experience in-
creased fatigue and lower physical function and activity dur-
ing and after chemotherapy, neither of which improve signif-
icantly without intervention [66]. Additionally, patients self-
report a lower quality of life during the first year of being
disease free compared to their perception of quality of life
prior to disease onset, as well as compared to 5-years after
being diagnosed with cancer [67]. This underscores the im-
portance of early intervention and for the rest of the cancer
survivor’s life. Different models have been proposed for this,
including the prospective surveillance model, in which pro-
viders follow patients from diagnosis, and through both onco-
logic treatment and rehabilitation [68, 69]. Depending on the
patient population, different approaches may be necessary,
such as an interdisciplinary team that addresses the challenges
faced by pediatric cancer survivors transitioning to adulthood
[70].
While rehabilitation and exercise have consistently been
shown to be beneficial across the cancer continuum including
in long-term survivors [71, 72, 73], it is unclear which spe-
cialty and care delivery model is best equipped to meet the
challenges of the growing cancer survivor population.
Primary care has taken up the mantle of managing deleterious
effects of cancer—the American Society of Clinical
Oncology’s Survivorship Symposium is a joint effort between
medical oncology and primary care—despite the fact that pri-
mary care physicians and oncologists both self-report not hav-
ing the proper training, nor the in-clinic time, to evaluate and
treat the physical and cognitive sequelae or cancer treatment
[74, 75]. Furthermore, when rehabilitation needs are diag-
nosed, referrals for rehabilitation services are lacking [76–78].
Physiatrists and other rehabilitation providers are uniquely
suited to manage neuromusculoskeletal and cognitive deficits
in cancer survivors, and their involvement may reduce unmet
rehabilitation needs in this population [16]. Improving func-
tion becomes all the more important when one considers that
weight gain is a risk factor for cancer recurrence among those
with no evidence of disease [79]. As the number of cancer
survivors and therefore study cohorts grow, research may help
determine the optimal pathway to long-term recovery; until
then, it is clear that patients must take ownership of their care
and empower themselves with all available resources [80].
Finally, rehabilitation has been consistently shown to help
cancer survivors return to work, which is beneficial both eco-
nomically and for patient well-being, as cancer survivors who
have job-loss related to a health issue have lower health-
related quality of life [81]. Fortunately, patients with support
from rehabilitation physicians, and their family and friends,
have not only been shown to be more likely to return to work
50 Curr Phys Med Rehabil Rep (2017) 5:46–54
but also to have a positive outlook on their employment de-
spite a potential change in function caused by cancer [82, 83].
In one study looking at high-intensity training in long-term
cancer survivors, rehabilitation interventions made it easier
to return to work [84]. A comprehensive, multidisciplinary
approach may be needed to help patients with no evidence
of disease return to work, particularly in patients with negative
predictors of returning to work, including older age, lower
income, history of chemotherapy, a job requiring heavy phys-
ical activity, and low education level [85].
Conclusion
A patient’s medical prognosis has the ability to impact reha-
bilitation and supportive measures in many ways, including
physician bias and resultant lack of proper referrals. Despite
this, rehabilitation interventions appear to be generally effec-
tive in improving function and reducing symptom burden in
cancer patients across the spectrum of different prognoses.
Unfortunately, studies evaluating interventions at the end of
life are limited, and more likely to be short series or case
reports, making the literature imbalanced in favor of interven-
tions in the earlier stages of disease [86]. This creates potential
physician bias and may explain some perceptions of rehabil-
itation in advanced disease.
Additionally, most of the available research focuses on pal-
liative care, which can include management of symptoms treat-
ed by rehabilitation providers, such as pain and functional im-
pairment, but is a broad topic, and the studies are often nonspe-
cific about what palliative care interventions are offered.
Although there is overlap between cancer rehabilitation and
palliative care, it is important to note that there are distinctions
in the two fields, primarily that palliative care typically ad-
dresses end of life considerations in more than just cancer pa-
tients—including spiritual and social or financial concerns—
and cancer rehabilitation emphasizes restoring function and re-
ducing symptom burden through identification and manage-
ment of specific impairments in cancer patients [29].
It is important that rehabilitation be considered in all
cancer patients who require it, regardless of prognosis.
The challenge facing clinicians and researchers is develop-
ing actionable rehabilitation referral mechanisms and inter-
ventions specifically tailored to patients at different points
of the disease continuum.
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